Effectiveness of smoking cessation interventions for smokers with Crohn's disease: a systematic review.

IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL

Future Science OA Pub Date : 2023-08-01 DOI:10.2144/fsoa-2022-0049

Sahar Nasr, Ilyess Nsiri, Manel Ben Fredj

{"title":"Effectiveness of smoking cessation interventions for smokers with Crohn's disease: a systematic review.","authors":"Sahar Nasr, Ilyess Nsiri, Manel Ben Fredj","doi":"10.2144/fsoa-2022-0049","DOIUrl":null,"url":null,"abstract":"Aims: Smoking cessation (SC) in Crohn's disease (CD) is widely accepted to be the most important modifiable factor to improve outcomes in these patients. We aimed in this review to provide a summary of the evidence base regarding the effectiveness of SC interventions in patients with CD.Materials & methods: The following databases were systematically searched from inception to February 2022: PubMed, Google Scholar and Cochrane Library.Results: Overall, five articles met the research criteria. Studies sample size ranged from 17 to 474 patients. At the outcome level, the abstinence rates ranged from 14.8 to 42% and was ≤25% in four studies. The three studies with control groups did not report statistically higher SC rates in the intervention groups. No predictors of interventions success were identified in this review.Conclusion: Implementation and evaluation of tailored SC interventions for CD patients must be promptly addressed in further studies.","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"9 7","pages":"FSO870"},"PeriodicalIF":2.4000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357394/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2144/fsoa-2022-0049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Aims: Smoking cessation (SC) in Crohn's disease (CD) is widely accepted to be the most important modifiable factor to improve outcomes in these patients. We aimed in this review to provide a summary of the evidence base regarding the effectiveness of SC interventions in patients with CD.

Materials & methods: The following databases were systematically searched from inception to February 2022: PubMed, Google Scholar and Cochrane Library.

Results: Overall, five articles met the research criteria. Studies sample size ranged from 17 to 474 patients. At the outcome level, the abstinence rates ranged from 14.8 to 42% and was ≤25% in four studies. The three studies with control groups did not report statistically higher SC rates in the intervention groups. No predictors of interventions success were identified in this review.

Conclusion: Implementation and evaluation of tailored SC interventions for CD patients must be promptly addressed in further studies.

Abstract Image

查看原文本刊更多论文

戒烟干预对患有克罗恩病的吸烟者的有效性:一项系统综述。

目的:戒烟(SC)在克罗恩病(CD)中被广泛认为是改善这些患者预后的最重要的可改变因素。我们在这篇综述中旨在总结关于SC干预对cd患者有效性的证据基础。材料和方法:从开始到2022年2月，系统地检索了以下数据库:PubMed, Google Scholar和Cochrane Library。结果:总体上有5篇文章符合研究标准。研究样本量从17例到474例不等。在结果水平上，4项研究的戒断率从14.8%到42%不等，≤25%。对照组的三项研究未发现干预组的SC率在统计学上较高。本综述未发现干预措施成功的预测因素。结论:在进一步的研究中，必须及时解决针对CD患者的定制SC干预措施的实施和评估。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future Science OA MEDICINE, RESEARCH & EXPERIMENTAL-

CiteScore

5.00

自引率

4.00%

发文量

审稿时长

13 weeks

期刊介绍： Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries